Intermountain Precision Genomics

Industry Award

Intermountain Precision Genomics

Intermountain Precision Genomics is being honored for genetically-targeted cancer innovations that are improving the lifespans and quality of life for thousands of Utah residents, placing Utah at the cutting edge of precision medicine. Precision Genomics, with its core laboratory located in St. George, Utah, has developed next-generation genomic technology that decodes the genetic makeup of each patient’s unique cancer cells to detect the individual genes contributing to their illness. These insights unlock the door to highly-effective, personalized treatment options, offering hope to patients who haven’t seen improvement from traditional treatment.

Placing Utah on the map for genetic innovations, Precision Genomics has sequenced more than 6,000 tissue samples since the company’s inception, with more than 75 percent of patients with advanced-stage cancer finding additional treatment options. In addition to its use of genomic technology in oncology, Precision Genomics is also using the technology to improve care of patients suffering from depression. Since the release of RxMatch in early 2018, Precision Genomics has provided medication screenings for 1,500 patients across more than eight clinical specialties.